GR 103691

CAS No. 162408-66-4

GR 103691( —— )

Catalog No. M23720 CAS No. 162408-66-4

GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 57 In Stock
2MG 33 In Stock
5MG 53 In Stock
10MG 93 In Stock
25MG 187 In Stock
50MG 299 In Stock
100MG 477 In Stock
200MG 677 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GR 103691
  • Note
    Research use only, not for human use.
  • Brief Description
    GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).
  • Description
    GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM). It shows more than 100-fold selectivity for human dopamine human (h)D3 over hD4 and hD1 sites.
  • In Vitro
    GR 103691 shows marked affinity for serotonin1A (5-HT1A) receptors (Ki of 5.8 nM) and α-1 adrenoceptors (Ki of 12.6 nM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    162408-66-4
  • Formula Weight
    485.62
  • Molecular Formula
    C30H35N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(C1=CC=C(C2=CC=C(C(C)=O)C=C2)C=C1)NCCCCN3CCN(C4=CC=CC=C4OC)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Audinot V, et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther. 1998 Oct;287(1):187-97.
molnova catalog
related products
  • CCT241736

    CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.

  • Pentiapine

    Pentiapine is a novel inhibitor of dopamine release.

  • GSK598809 hydrochlor...

    GSK598809 hydrochloride is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.